Soligenix
SNGX
#10223
Rank
ยฃ12.18 M
Marketcap
ยฃ1.21
Share price
-1.23%
Change (1 day)
-51.81%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.28 Million

According to Soligenix's latest financial reports the company's total debt is ยฃ0.28 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ1.18 M-56.87%
2023-12-31ยฃ2.74 M-67.59%
2022-12-31ยฃ8.46 M14.69%
2021-12-31ยฃ7.38 M-4.25%
2020-12-31ยฃ7.7 M7844.4%
2019-12-31ยฃ0.09 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31ยฃ0.19 M-91.88%
2014-12-31ยฃ2.43 M-51.52%
2013-12-31ยฃ5.02 M
2004-12-31ยฃ0.06 M-69.91%
2003-12-31ยฃ0.2 M-55.91%
2002-12-31ยฃ0.45 M204.4%
2001-12-31ยฃ0.14 M-30.88%
2000-12-31ยฃ0.21 M-10.86%
1999-12-31ยฃ0.24 M0.91%
1998-12-31ยฃ0.24 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.49 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ19.16 B 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ45.67 B 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ34.37 B 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ13.94 M 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.81 B 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel